|
|
Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.
More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.
By definition, when a medication is administered intravenously, its bioavailability is 100%.
The heart is located in the center of the chest, with part of it tipped slightly so that it taps against the left side of the chest.
Sperm cells are so tiny that 400 to 500 million (400,000,000–500,000,000) of them fit onto 1 tsp.